loratadine has been researched along with olopatadine hydrochloride in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abelson, MB; Lanier, RQ | 1 |
Abelson, MB; Welch, DL | 1 |
Cockrum, PC; Gross, RD; Juniper, EF; Lanier, BQ; Marks, BB | 1 |
Aragane, Y; Ashenager, MS; Grgela, T; Kawada, A | 1 |
3 trial(s) available for loratadine and olopatadine hydrochloride
Article | Year |
---|---|
The added benefit of local Patanol therapy when combined with systemic Claritin for the inhibition of ocular itching in the conjunctival antigen challenge model.
Topics: Administration, Oral; Adult; Allergens; Conjunctivitis, Allergic; Dibenzoxepins; Double-Blind Method; Drug Therapy, Combination; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Olopatadine Hydrochloride; Ophthalmic Solutions; Safety; Treatment Outcome | 1999 |
An evaluation of onset and duration of action of patanol (olopatadine hydrochloride ophthalmic solution 0.1%) compared to Claritin (loratadine 10 mg) tablets in acute allergic conjunctivitis in the conjunctival allergen challenge model.
Topics: Acute Disease; Allergens; Conjunctivitis, Allergic; Dibenzoxepins; Double-Blind Method; Drug Evaluation; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Models, Biological; Olopatadine Hydrochloride; Ophthalmic Solutions; Tablets; Time Factors | 2000 |
Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms.
Topics: Adolescent; Adult; Aged; Asthenia; Child; Conjunctivitis, Allergic; Dibenzoxepins; Drug Therapy, Combination; Dyspepsia; Female; Humans; Loratadine; Male; Middle Aged; Olopatadine Hydrochloride; Xerostomia | 2001 |
1 other study(ies) available for loratadine and olopatadine hydrochloride
Article | Year |
---|---|
Inhibition of cytokine-induced expression of T-cell cytokines by antihistamines.
Topics: Cells, Cultured; Cetirizine; Dibenzoxepins; Histamine H1 Antagonists, Non-Sedating; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-12; Interleukin-4; Interleukin-5; Loratadine; Olopatadine Hydrochloride; RNA, Messenger; T-Lymphocytes; Terfenadine | 2007 |